Candela gears up for ScleroLaser launch:
This article was originally published in Clinica
Executive Summary
Candela plans to launch ScleroLaser later this quarter. The leg-vein treatment system has gone into production and will be launched at the American Academy of Dermatology annual meeting in Washington in February, along with recent clinical data. The FDA cleared the laser in April 1995 (see Clinica No 653, p19).